Pharmafile
APRIL 5, 2023
The FDA has announced that it will require opioid analgesic manufacturers to provide prepaid mail-back envelopes in outpatient pharmacies and dispensers as an additional disposal option for patients.
PharmaVoice
APRIL 6, 2023
Pharming just landed an FDA approval for a treatment targeting an ultra-rare immunodeficiency disorder discovered only a decade ago — and it’s already in the hands of patients.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmafile
APRIL 4, 2023
The FDA has published a report revealing that Global Pharma’s plant in India’s Chennai city failed to achieve safety norms throughout multiple observations. In February 2023, the eye drops, under the brand names EzriCare Artificial Tears and Delsam Pharma’s Artificial Tears, were recalled after a recommendation from the FDA, which then stopped the import of the products to the US.
Drug Topics
APRIL 5, 2023
The biopharmaceutical company says it is “extremely disappointed” with the results of the COURAGE-ALS study, which failed to meet primary or secondary endpoints.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PhRMA
APRIL 6, 2023
Next week, the Medicare Payment Advisory Commission (MedPAC) will vote on a number of policy proposals for changing Medicare Part B. One of the proposals would recommend that Congress adjust the payment for Part B medicines with accelerated approval , including medicines for serious and life-threatening diseases like cancers, rare diseases and HIV. This could compromise patient access to medicines, which is the opposite of what accelerated approval is designed to do.
PharmaVoice
APRIL 4, 2023
A report from accounting firm BDO compares biotech’s tough times with the booming last few years — and points to some silver linings.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Topics
APRIL 5, 2023
Members of the Senate Finance Committee are pushing PBMs to modernize the rules regarding out of pocket costs and competition.
PhRMA
APRIL 7, 2023
PhRMA president and CEO Stephen J. Ubl spoke recently at The Hill’ s event, “ Pathways to Patient Affordability.” He spotlighted patients’ affordability challenges, the unintended consequences we’re already seeing from the government price setting provisions in the Inflation Reduction Act (IRA) and how policymakers can address harmful pharmacy benefit manager (PBM) practices.
PharmaVoice
APRIL 3, 2023
New reports highlight the need for more targeted biotech education curriculums to shore up a sustainable workforce.
Fierce Healthcare
APRIL 7, 2023
Layoffs are ramping up among hospitals and health systems.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
APRIL 7, 2023
Both acute and chronic infection can increase the risk of cognitive decline and dementia in older adults.
PhRMA
APRIL 4, 2023
This week marks a somber anniversary for patients with Alzheimer’s. Last year, the Centers for Medicare & Medicaid Services (CMS) finalized a national coverage determination (NCD) that, for the first time ever, uses a coverage with evidence development (CED) policy that forces Medicare patients into highly restrictive research studies to simply gain access to new Alzheimer’s medicines that have been approved by the U.S.
PharmaVoice
APRIL 3, 2023
In the red-hot race for new schizophrenia treatments, Karuna Therapeutics is close to an FDA submission.
Fierce Healthcare
APRIL 4, 2023
6 megadeals made up 40% of digital health funding in Q1 as smaller startups face rough waters: Rock Health hlandi Tue, 04/04/2023 - 14:40
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Drug Topics
APRIL 6, 2023
The FDA has finally decided to withdraw approval of Makena and its generics after Covis Pharma volunteered to remove the drug from market in March.
PhRMA
APRIL 5, 2023
The United States will soon reach an important milestone in the COVID-19 pandemic: the official end of the federal public health emergency (PHE). According to the U.S. Department of Health and Human Services (HHS), the COVID-19 PHE will expire on May 11, 2023. This significant transition has been made possible, in part, by the biopharmaceutical industry’s continuing efforts to research, develop and manufacture safe, effective treatments and vaccines for COVID-19.
Fierce Pharma
APRIL 3, 2023
After Johnson & Johnson loses again in bankruptcy case, it's game on for talc lawsuits kdunleavy Mon, 04/03/2023 - 06:44
STAT
APRIL 4, 2023
For the first time, Mark Cuban’s Cost Plus Drug Company is selling medicines made by a large drug manufacturer directly to consumers at a greatly reduced price, the latest sign that the billionaire is trying to make good on his vow to disrupt the opaque pharmaceutical supply chain. Until now, the company has focused on selling generic versions of brand-name medicines.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Topics
APRIL 3, 2023
The new feature automatically applies manufacturer-sponsored coupons directly to an eligible patient’s order. So far, only a few pharma companies have made their coupons available through Amazon.
PhRMA
APRIL 4, 2023
Recently, Arkansas became the latest state to enact a law so that many patients aren’t paying more for their medicines than their insurance company or pharmacy benefit manager (PBM). The policy, commonly referred to as “share the savings,” requires insurers and the PBMs they work with to share the rebates, discounts, and other price concessions they receive from manufacturers directly with patients at the pharmacy counter.
Fierce Healthcare
APRIL 4, 2023
From 'transformative' to 'tremendous fear': Takes on ChatGPT in healthcare at ViVE 2023 hlandi Tue, 04/04/2023 - 06:25
STAT
APRIL 3, 2023
One in six people across the globe face infertility at some point in their lifetime, according to the first new estimates from the World Health Organization in a decade. The prevalence is “staggering,” Pascale Allotey, director of sexual and reproductive health and research at WHO, said at a press conference Monday. The report estimates that 17.8% of adults in high-income countries and 16.5% in low- and middle-income countries experience infertility.
Drug Topics
APRIL 4, 2023
Health care advocates provide a vital service for patients who are managing chronic conditions.
Pharmacy Times
APRIL 7, 2023
Discussions are led by a variety of experienced preceptors to provide insight, strategies, and resources for pharmacy residents.
PharmaVoice
APRIL 7, 2023
The company’s chief operating and growth officer on her personal quirks and why every pharma leader should read "Getting Naked.
STAT
APRIL 3, 2023
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the second quarter: When is “mid-year”? This is not an existential question. Practically speaking, when a drugmaker, let’s say Bridge Bio , tells investors that an important readout of all-cause mortality data from a clinical trial of its heart drug acoramidis is coming “mid-2023,” does that mean the end of June or the beginning of July?
Drug Topics
APRIL 6, 2023
Data reveal 50% of meningitis vaccination appointments were delayed or canceled amid the COVID-19 pandemic, leading authors of a survey to highlight the need for “urgent action” to maintain routine vaccination levels among children.
Pharmacy Is Right For Me
APRIL 4, 2023
There are so many different types of careers within the field of pharmacy—from research and drug development to pharmacy informatics! To learn about some of the more unique career settings in the industry, check out the Novel Pharmacy Practice Settings page —where you can explore these unique career pathways such as integrated health-community paramedicine.
PharmaVoice
APRIL 6, 2023
Although Janssen bowed out of the RSV vaccine race, several pharmas are quickly closing in on the finish line in a disease with decades of unmet need.
STAT
APRIL 7, 2023
I care deeply about privacy, and as a professional researcher, I take meticulous notes. During my recent maternity leave, I spent most of my hands-free time trying to figure out why my doctors were trying to give my medical data away to advertisers — even after I opted out.
Drug Topics
APRIL 4, 2023
During a session at the 2023 HOPA Annual Conference, Rebecca Champion, PharmD, BCOP, highlighted new therapies in the market for hematologic malignancies with a focus on bispecific antibodies and chimeric antigen receptor T-cell therapies.
Pharmacy Is Right For Me
APRIL 3, 2023
Pharmacy is a field of study and practice that may have historically been male-dominated, but now an estimated 65% of pharmacists in the United States are women! And there are many benefits to women who pursue pharmacy as a career. Job stability and growth Pharmacy is a rapidly growing field that’s expected to continue to grow in the coming years. The Bureau of Labor Statistics projects that the employment of pharmacists will increase by 3% from 2020 to 2030.
PharmaVoice
APRIL 5, 2023
A VP of global development at Amgen explains how treating general medicine diseases could one day resemble approaches in oncology.
Expert insights. Personalized for you.
64 
Let's personalize your content